Aptus Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹49 crore and net profit of ₹5.08 crore for the September 2026 quarter.
Aptus Pharma (BSE: APPL) closed at ₹487.45 on 20 Nov 2026, up 692.6% over the past year. Its market capitalisation is ₹836 crore and it trades at 105.2 times earnings.
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.